Patents by Inventor John Dankwardt

John Dankwardt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted heteroaryl derivatives, compositions, and methods of use
    Patent number: 7820704
    Abstract: The present invention provides substituted heteroaryl derivatives of Formula (I), methods of their preparation, pharmaceutical compositions comprising the compounds of Formula (I), and methods of use in treating human or animal disorders. The compounds of the invention can be useful as inhibitors of action of AgRP on a melanocortin receptor and thus can be useful for the management, treatment, control, or the adjunct treatment of diseases which may be responsive to the modulation of melanocortin receptors including obesity-related disorders.
    Type: Grant
    Filed: April 20, 2005
    Date of Patent: October 26, 2010
    Assignee: TransTech Pharma, Inc.
    Inventors: Adnan M. M. Mjalli, Bapu R. Gaddam, Ghassan Qabaja, Govindan Subramanian, Jeff Zhu, John Dankwardt, Murty N. Arimilli, Robert C. Andrews, Samuel Victory, Ye E. Tian
  • Nickel catalyzed cross-coupling reactions between organomagnesium compounds and anisole derivatives
    Publication number: 20060240976
    Abstract: The present invention provides nickel catalysts and solvents which are useful in a cross-coupling reaction between an organomagnesium compound and an aromatic ether compound, such as an anisole derivative.
    Type: Application
    Filed: June 21, 2006
    Publication date: October 26, 2006
    Inventor: John Dankwardt
  • Substituted heteroaryl derivatives, compositions, and methods of use
    Publication number: 20050261294
    Abstract: The present invention provides substituted heteroaryl derivatives of Formula (I), methods of their preparation, pharmaceutical compositions comprising the compounds of Formula (I), and methods of use in treating human or animal disorders. The compounds of the invention can be useful as inhibitors of action of AgRP on a melanocortin receptor and thus can be useful for the management, treatment, control, or the adjunct treatment of diseases which may be responsive to the modulation of melanocortin receptors including obesity-related disorders.
    Type: Application
    Filed: April 20, 2005
    Publication date: November 24, 2005
    Inventors: Adnan Mjalli, Bapu Gaddam, Ghassan Qabaja, Govindan Subramanian, Jeff Zhu, John Dankwardt, Murty Arimilli, Robert Andrews, Samuel Victory, Ye Tian
  • Nickel catalyzed cross-coupling reactions between organomagnesium compounds and anisole derivatives
    Publication number: 20050010073
    Abstract: The present invention provides nickel catalysts and solvents which are useful in a cross-coupling reaction between an organomagnesium compound and an aromatic ether compound, such as an anisole derivative.
    Type: Application
    Filed: July 8, 2003
    Publication date: January 13, 2005
    Applicant: DSM IP Assets B.V.
    Inventor: John Dankwardt